Eli Lilly and Company LLY
announced today that a Phase III study, published online by European Urology,
showed both Cialis and tamsulosin significantly improved scores
on the International Prostate Symptom Score, compared to placebo, in
men with signs and symptoms suggestive of benign prostatic hyperplasia.
Cialis improved erectile dysfunction in those men who had both signs and
symptoms of BPH and ED. The study also showed that maximum urinary flow rate
increased significantly versus placebo with both Cialis and tamsulosin. This
is the first international, placebo-controlled study evaluating Cialis in
parallel with tamsulosin for signs and symptoms of BPH
in the same population.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in